Georgiamune

Gaithersburg, United States

Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases.

$75.0M raised

Aug 2023

Series A

Biotechnology Health Care Therapeutics

Top Investors

General CatalystCatalio Capital ManagementVerition Fund ManagementAlexandria Venture InvestmentsBioventures Investors

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Georgiamune

How much funding has Georgiamune raised?

Georgiamune has raised $75.0M in total funding. The most recent round was Series A. The last funding was announced in August 2023.

Who are Georgiamune's investors?

Georgiamune's investors include General Catalyst, Catalio Capital Management, Verition Fund Management, Alexandria Venture Investments, Bioventures Investors.

Where is Georgiamune headquartered?

Georgiamune is headquartered in Gaithersburg, United States.

What does Georgiamune do?

Georgiamune is a biotechnology company developing next-generation immunotherapeutics for cancer and autoimmune diseases.

What stage is Georgiamune at?

Georgiamune is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 9, 2023.

MLA

"Georgiamune — Funding & Investors." VCBacked, August 9, 2023, https://www.vcbacked.co/company/georgiamune. Accessed June 16, 2026.

APA

VCBacked. (2023). Georgiamune — Funding & Investors. Retrieved June 16, 2026, from https://www.vcbacked.co/company/georgiamune

Wikipedia (cite web)

{{cite web |title=Georgiamune — Funding & Investors |url=https://www.vcbacked.co/company/georgiamune |website=VCBacked |access-date=June 16, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 9, 2023.

Similar Companies in Biotechnology